End points in chronic heart failure clinical trials

Keyphrases

• Clinical Trials 100%
• Chronic Heart Failure 100%
• Surrogate Endpoint 100%
• Clinically Significant 33%
• Disease Mechanisms 33%
• Specific Interventions 33%
• Therapeutic Agents 33%
• Biologically Relevant 33%
• Randomized Clinical Trial 33%
• Clinical Benefit 33%
• Disease Process 33%
• Composite Endpoint 33%
• Patients with Chronic Heart Failure 33%
• Large Sample Size 33%
• Mechanism of Drug Action 33%
• Sequential Trials 33%
• Diminishing Rates 33%
• Heart Failure Medication 33%

Medicine and Dentistry

• Clinical Trial 100%
• Congestive Heart Failure 100%
• Clinical Study 33%
• Therapeutic Agent 33%
• Disease Process 33%
• Randomized Clinical Trials 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Congestive Heart Failure 100%
• Clinical Study 33%
• Randomized Clinical Trial 33%
• Diseases 33%